FBIO Fortress Biotech Inc

Fortress Biotech Inc is a biopharmaceutical company. The Company is engaged in the development of novel immunotherapy agents for the treatment of autoimmune diseases and cancer.

$5.44  +0.56 (11.37%)
As of 04/09/2021 15:59:50 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  12/19/2011
Outstanding shares:  94,907,448
Average volume:  2,293,055
Market cap:   $516,296,517
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    34960Q109
ISIN:        US34960Q1094
Sedol:      BWT3FG4
Valuation   (See tab for details)
PE ratio:   -11.10
PB ratio:   5.14
PS ratio:   11.32
Return on equity:   -46.37%
Net income %:   -102.03%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy